| Symbol | RPRX |
|---|---|
| Name | ROYALTY PHARMA PLC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 110 EAST 59TH STREET,FL 33, NEW YORK, New York, 10022, United States |
| Telephone | +1 212 883-0200 |
| Fax | — |
| — | |
| Website | https://www.royaltypharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001802768 |
| Description | Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industrys therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnsons Imbruvica, Astellas and Pfizers Xtandi, Biogens Tysabri, Johnson & Johnsons Tremfya, Gileads Trodelvy, Mercks Januvia, Novartis Promacta, Vertexs Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. Additional info from NASDAQ: |
New Form 13F-NT - Royalty Pharma plc <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001802768-26-000018 <b>Size:</b> 3 KB
Read more📋 Terrance Coyne (Officer) plans to sell 11K shares of Royalty Pharma plc (at $58.56 each, total $644K) Filed: Aug 13, 2026 | ID: 000508
Read more📋 Errol B. De Souza (Ex-Affiliate) plans to sell 206K shares of Royalty Pharma plc (at $57.79 each, total $11.9M) Filed: Aug 12, 2026 | ID: 000828
Read more📋 Errol B. De Souza (Ex-Affiliate) plans to sell 125K shares of Royalty Pharma plc (at $57.79 each, total $7.2M) Filed: Aug 12, 2026 | ID: 000827
Read moreRoyalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
Read moreRoyalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
Read moreDirector Legorreta Pablo G. 🟡 adjusted position in 57.1M shares (4 derivative) of Royalty Pharma plc (RPRX) Transaction Date: Aug 05, 2026 | Filing ID: 000006
Read moreCoyne Terrance P. 🟡 adjusted position in 7.5K shares (1 derivative) of Royalty Pharma plc (RPRX) Transaction Date: Aug 05, 2026 | Filing ID: 000025
Read moreHite Christopher 🟢 acquired 11.0K shares of Royalty Pharma plc (RPRX) Transaction Date: Aug 05, 2026 | Filing ID: 000013
Read moreUrist Marshall 🟡 adjusted position in 21.7K shares (1 derivative) of Royalty Pharma plc (RPRX) Transaction Date: Aug 05, 2026 | Filing ID: 000024
Read more